Eisai Gives Full Aduhelm Responsibility To Biogen Under Amended Agreement

Japanese Pharma Trades 50-50 Deal For Single-Digit Royalty

Close-up Of A Businessperson Passing Baton
Eisai passed full Aduhelm decision-making authority to Biogen • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business